https://www.selleckchem.com/products/cc-92480.html
The observed OSR at 2 years was 64% (n=3 in the colon and 67% (n=14) in the rectal cancer patients. Thrombocytopenia (17, 11.7%) and diarrhea (8, 5.5%) were the most commonly observed grade 3/4 hematological and gastrointestinal toxicities. Hand-foot syndrome and peripheral neuropathy were the major contributors for dose reduction (14, 9.6%), treatment delay (8, 5.4%), and drug discontinuation (9, 6.1%) in the study cohort. CAPOX treatment was found to be effective but associated with several dose-limiting toxicities. CAPOX treatment
Curtir
Comentario
Compartilhar
